Veryan was formed in 2003 as the result of a technology spin out from Imperial College, London, UK. Veryan has designed, patented and developed a highly innovative three dimensional (3D) Nitinol (nickel-titanium alloy) stent technology – BioMimics 3D – based on the pioneering work by Professor Colin Caro (Emeritus Professor of Physiological Mechanics, Dept. of Bioengineering, Imperial College London) on the link between vessel geometry, blood flow mechanics and vascular disease.1

Veryan benefits from a highly experienced Board of Directors and the Company’s management team has built an outstanding development group, supported by a world class Scientific Advisory Board. The Company’s head office is in Horsham, West Sussex, UK, and the research and development facility is in Galway, Ireland.

Our focus

Veryan focuses on developing innovative devices for use in peripheral interventional procedures. Our design teams between them have decades of experience developing pioneering, minimally-invasive, catheter-based technologies used by international radiologists, cardiologists and vascular surgeons.

Growth of our product portfolio

Challenging the way things have always been done, bringing new and different ideas, seeking new solutions, shaping the future. We aim to stand out from the crowd as real innovators, looking to nature and cutting-edge science to solve some of the most complex human healthcare issues.

These clinically proven, intelligently designed peripheral interventional devices will bring together imagination, intuition and innovation.

Going further

When Veryan became an Otsuka Medical Devices company it opened up a world of exciting opportunities. Not only can we now have a global footprint but we can expand our Research and Development effort to create new products.

Veryan is also joining forces with other innovative organisations to make design-led products available to as many people as possible.

The future is exciting.

Imperial Innovations Group Plc – Uncovering the unquoted potential